​​​​​​​​​​​​​​​Molecular Pathology Publications​ 2024​

January-March​

  • Analysis of differential expression of matrix metallopr​oteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases. Imtiaz K, Farooqui N, Ahmed K, Zhamalbekova A, Anwar MF, Na​sir A, Ansar Z, Gul K, Hussain A, Sarría-Santamera A, and Abidi SH.​ ​PLoS One. 2025 Feb 18;20(2):e0304311.​ DOI: 10.1371/journal.pone.0304311

    ​​

  • ​Pre-existing IgG antibodies to HCoVs NL63 and OC43 Spike increased during the pandemic and after COVID-19 vaccination. Hasan Z, Masood KI, Veldhoen M, Qaiser S, Alenquer M, Akhtar M, Balouch S, Iqbal J, Wassan Y, Hussain S, Feroz K, Muhammad S, Habib A, Kanji A, Khan E, Mian AA, Hussain R, A​​morim MJ, and Bhutta ZA. Heliyon. 2025 Jan 22;11(3):e42171. DOI: 10.1016/j.heliyon.2025.e42171


  • ​Evidence of rapid rise in population​​ immunity from SARS-CoV-2 subclinical infections through pre-vaccination serial serosurveys in Pakistan. Iqbal J, Hasan Z, Habib MA, Malik AA, Muhammad S, Begum K, Zuberi R, Umer M, Ikram A, Soofi SB, Cousens S, and Bhutta ZA. J Glob Health. 2025 Feb 21;15:04078.​ ​DOI: 10.7189/jogh.15.04078


  • ​Optimizing Diagnostic Tools & Outcomes Evaluation for t (9;22)-Positive Leukemias in Pediatric Low Middle-Income Country (LMIC) Patients. Bukhari SI, Altaf S, Saleem H, Fadoo Z, Belgaumi AF, Moatter T and Ansar Z. Cancer Invest. 2025 Jan 24:1-11. ​​​​DOI: 10.1080/0735790​​7.2025.2457144